Metformin as an Emerging Candidate for Diabetic Retinopathy, Agerelated Macular Degeneration and Glaucoma Pharmacotherapy: Evidence and Perspectives

Marianne Levon Shahsuvaryan

Open source

DOI
10.2174/0127724328519947260917114932
Published
2026-09-24
Container
Current Reviews in Clinical and Experimental Pharmacology
Publisher
Bentham Science Publishers Ltd.
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.2174/0127724328519947260917114932,
  title = {Metformin as an Emerging Candidate for Diabetic Retinopathy, Agerelated Macular Degeneration and Glaucoma Pharmacotherapy: Evidence and Perspectives},
  author = {Marianne Levon Shahsuvaryan},
  year = {2026},
  journal = {Current Reviews in Clinical and Experimental Pharmacology},
  doi = {10.2174/0127724328519947260917114932},
  url = {https://doi.org/10.2174/0127724328519947260917114932}
}

RIS

TY  - JOUR
TI  - Metformin as an Emerging Candidate for Diabetic Retinopathy, Agerelated Macular Degeneration and Glaucoma Pharmacotherapy: Evidence and Perspectives
AU  - Marianne Levon Shahsuvaryan
PY  - 2026
JO  - Current Reviews in Clinical and Experimental Pharmacology
DO  - 10.2174/0127724328519947260917114932
UR  - https://doi.org/10.2174/0127724328519947260917114932
ER  - 

APA

Shahsuvaryan, M. L. (2026). Metformin as an Emerging Candidate for Diabetic Retinopathy, Agerelated Macular Degeneration and Glaucoma Pharmacotherapy: Evidence and Perspectives. Current Reviews in Clinical and Experimental Pharmacology. https://doi.org/10.2174/0127724328519947260917114932

Source records